retatrutide resukts 💉 may be redefining obesity treatment. New data from TRIUMPH-1 Trial showed: 🔥 ~28% average weight loss over 80 weeks 🔥 >30% weight loss in nearly half of participant #ObesityMedicine #Retatrutide #GLP1 #CardioMetabolic The experimental GLP-1 drug 'reta'

Nat Rev Nephrol 22 , 265282 (2026)

These medications effectively slow gastric emptying, which has raised concerns regarding the risk of residual gastric volume (RGV) and potential pulmonary aspiration during procedures requiring sedation

While no official Indian launch timeline has been confirmed, recent reports suggest Eli Lilly is progressing toward regulatory submissions following successful Phase 3 trial results

277,278,279,280 This effect is accomplished through the inhibition of JNK, NF-B, and other relevant signaling pathways

GLP-1 receptors are present not only in the pancreas but also extensively throughout the gastrointestinal system

10.1016/j.intimp.2022.109653 Int